Genentech and a former worker who accused the biotechnology company in a lawsuit of overcharging employees in 401(k) recordkeeping fees agreed to move the suit forward as a class, and asked a California federal judge to approve the action estimated to represent 30,000 members.
Membrane-bound E3 ubiquitin ligases RNF43 and ZNRF3 are overexpressed in colorectal cancer, and can be repurposed using proteolysis-targeting antibodies (PROTABs) to selectively degrade cell-surface receptors in tumours.
In this webinar, ‘proton, fluorine and X’, Ron Crouch (JEOL) outlines the successful use of isotope shifts in the correct assignment of perfluoro substances. The second participant is Dave Russell (Genentech), who explores the use of the 3-channel HFX-NMR system in drug discovery.
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its prop
Coherus BioSciences’ ranibizumab-eqrn is the first and only FDA-approved biosimilar interchangeable with ranibizumab injection for all indications, with 12 months of interchangeability exclusivity.
Researchers studied the effect of pirfenidone on the progression of lung disease in patients with rheumatoid arthritis-associated interstitial lung disease.
There are thousands of diseases classed as “rare” because they afflict only a small number of people. These patient groups were long ignored by a pharmaceutical industry that judged them too small to provide a return on the investment needed to develop an effective remedy. Forty years ago, a revolut…
Marginal Zone Lymphoma Pipeline constitutes 40+ key companies continuously working towards developing 50+ Marginal Zone Lymphoma treatment therapies,...
Researchers describe in Science Translational Medicine mechanisms behind some treatment resistance in breast cancer.
The challenges and opportunities of employment will be the focus of the next Solano Economic Development Corporation speaker series event set for Sept. 27. Jeremiah Gill, vice president of HR Consulting-Program Offices at Kaiser Permanente; Trish Sur, senior director of People and Cultur
Double Take was designed to showcase adaptive fashion for people with disabilities.
Use against pair of pathways could pave way for standout in stocked eye disease market.
On August 31, 2022, Biocon Biologics released a statement regarding three recent on-site FDA inspections of seven manufacturing facilities...
Health-care companies rose as traders continued to pile into the biotechnology niche, reflecting a resurgence in risk appetite. Shares of Bayer rose after...
Pharm Exec releases its annual product launch feature articles.
” Get Sample Report Buy Complete Report New Jersey (United States) – The Pulmonary Embolism Drug Market research report provides all the information related to the industry. It gives the market’s outlook by giving authentic data to its client, which helps to make essential decisions. It provides a…
Employees say: “The people are simply amazing to work with and the company has cultivated a culture that encourages growth and development outside of each individual’s assigned function. It is important to me to have to be able to contribute to the company vision to help the patients with unmet need…
Eleven SMA patients are in Double Take, a Sept. 8 runway show ahead of New York Fashion Week, sporting clothes designed for accessibility.
LEXINGTON, Mass., Sept. 7, 2022 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James